121 related articles for article (PubMed ID: 8331726)
21. Efficient c-kit receptor-targeted gene transfer to primary human CD34-selected hematopoietic stem cells.
Zhong Q; Oliver P; Huang W; Good D; La Russa V; Zhang Z; Cork JR; Veith RW; Theodossiou C; Kolls JK; Schwarzenberger P
J Virol; 2001 Nov; 75(21):10393-400. PubMed ID: 11581407
[TBL] [Abstract][Full Text] [Related]
22. Identification of envelope determinants of feline leukemia virus subgroup B that permit infection and gene transfer to cells expressing human Pit1 or Pit2.
Sugai J; Eiden M; Anderson MM; Van Hoeven N; Meiering CD; Overbaugh J
J Virol; 2001 Aug; 75(15):6841-9. PubMed ID: 11435563
[TBL] [Abstract][Full Text] [Related]
23. Functional characterization of the N termini of murine leukemia virus envelope proteins.
Lu CW; Roth MJ
J Virol; 2001 May; 75(9):4357-66. PubMed ID: 11287584
[TBL] [Abstract][Full Text] [Related]
24. Activation of membrane fusion by murine leukemia viruses is controlled in cis or in trans by interactions between the receptor-binding domain and a conserved disulfide loop of the carboxy terminus of the surface glycoprotein.
Lavillette D; Boson B; Russell SJ; Cosset FL
J Virol; 2001 Apr; 75(8):3685-95. PubMed ID: 11264358
[TBL] [Abstract][Full Text] [Related]
25. Efficient cell infection by Moloney murine leukemia virus-derived particles requires minimal amounts of envelope glycoprotein.
Bachrach E; Marin M; Pelegrin M; Karavanas G; Piechaczyk M
J Virol; 2000 Sep; 74(18):8480-6. PubMed ID: 10954548
[TBL] [Abstract][Full Text] [Related]
26. Feline leukemia virus envelope sequences that affect T-cell tropism and syncytium formation are not part of known receptor-binding domains.
Gwynn SR; Hankenson FC; Lauring AS; Rohn JL; Overbaugh J
J Virol; 2000 Jul; 74(13):5754-61. PubMed ID: 10846053
[TBL] [Abstract][Full Text] [Related]
27. Second-site changes affect viability of amphotropic/ecotropic chimeric enveloped murine leukemia viruses.
O'Reilly L; Roth MJ
J Virol; 2000 Jan; 74(2):899-913. PubMed ID: 10623753
[TBL] [Abstract][Full Text] [Related]
28. Activation of a cell entry pathway common to type C mammalian retroviruses by soluble envelope fragments.
Lavillette D; Ruggieri A; Russell SJ; Cosset FL
J Virol; 2000 Jan; 74(1):295-304. PubMed ID: 10590117
[TBL] [Abstract][Full Text] [Related]
29. Receptor-mediated Moloney murine leukemia virus entry can occur independently of the clathrin-coated-pit-mediated endocytic pathway.
Lee S; Zhao Y; Anderson WF
J Virol; 1999 Jul; 73(7):5994-6005. PubMed ID: 10364351
[TBL] [Abstract][Full Text] [Related]
30. The hypervariable domain of the murine leukemia virus surface protein tolerates large insertions and deletions, enabling development of a retroviral particle display system.
Kayman SC; Park H; Saxon M; Pinter A
J Virol; 1999 Mar; 73(3):1802-8. PubMed ID: 9971757
[TBL] [Abstract][Full Text] [Related]
31. Role of variable regions A and B in receptor binding domain of amphotropic murine leukemia virus envelope protein.
Han JY; Zhao Y; Anderson WF; Cannon PM
J Virol; 1998 Nov; 72(11):9101-8. PubMed ID: 9765455
[TBL] [Abstract][Full Text] [Related]
32. Functional domains in the retroviral transmembrane protein.
Zhao Y; Zhu L; Benedict CA; Chen D; Anderson WF; Cannon PM
J Virol; 1998 Jul; 72(7):5392-8. PubMed ID: 9620993
[TBL] [Abstract][Full Text] [Related]
33. Characterization of the proline-rich region of murine leukemia virus envelope protein.
Weimin Wu B; Cannon PM; Gordon EM; Hall FL; Anderson WF
J Virol; 1998 Jul; 72(7):5383-91. PubMed ID: 9620992
[TBL] [Abstract][Full Text] [Related]
34. Mutational analysis of the fusion peptide of Moloney murine leukemia virus transmembrane protein p15E.
Zhu NL; Cannon PM; Chen D; Anderson WF
J Virol; 1998 Feb; 72(2):1632-9. PubMed ID: 9445069
[TBL] [Abstract][Full Text] [Related]
35. Definition of a 14-amino-acid peptide essential for the interaction between the murine leukemia virus amphotropic envelope glycoprotein and its receptor.
Battini JL; Danos O; Heard JM
J Virol; 1998 Jan; 72(1):428-35. PubMed ID: 9420242
[TBL] [Abstract][Full Text] [Related]
36. Three distinct envelope domains, variably present in subgroup B feline leukemia virus recombinants, mediate Pit1 and Pit2 receptor recognition.
Boomer S; Eiden M; Burns CC; Overbaugh J
J Virol; 1997 Nov; 71(11):8116-23. PubMed ID: 9343161
[TBL] [Abstract][Full Text] [Related]
37. Identification of envelope protein residues required for the expanded host range of 10A1 murine leukemia virus.
Han JY; Cannon PM; Lai KM; Zhao Y; Eiden MV; Anderson WF
J Virol; 1997 Nov; 71(11):8103-8. PubMed ID: 9343159
[TBL] [Abstract][Full Text] [Related]
38. In vitro binding of purified murine ecotropic retrovirus envelope surface protein to its receptor, MCAT-1.
Davey RA; Hamson CA; Healey JJ; Cunningham JM
J Virol; 1997 Nov; 71(11):8096-102. PubMed ID: 9343158
[TBL] [Abstract][Full Text] [Related]
39. Functional interactions between monomers of the retroviral envelope protein complex.
Zhao Y; Lee S; Anderson WF
J Virol; 1997 Sep; 71(9):6967-72. PubMed ID: 9261425
[TBL] [Abstract][Full Text] [Related]
40. Receptor co-operation in retrovirus entry: recruitment of an auxiliary entry mechanism after retargeted binding.
Valsesia-Wittmann S; Morling FJ; Hatziioannou T; Russell SJ; Cosset FL
EMBO J; 1997 Mar; 16(6):1214-23. PubMed ID: 9135138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
